NDC 36987-1960

Curvularia inaequalis

Curvularia Inaequalis

Curvularia inaequalis is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Curvularia Inaequalis.

• Product ID: 36987-1960_9010bf62-c443-49a9-b8f8-fa8dd9223885
• NDC: 36987-1960
• Product Type: Human Prescription Drug
• Proprietary Name: Curvularia inaequalis
• Generic Name: Curvularia Inaequalis
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1972-08-29
• Marketing Category: BLA / BLA
• Application Number: BLA102192
• Labeler Name: Nelco Laboratories, Inc.
• Substance Name: CURVULARIA INAEQUALIS
• Active Ingredient Strength: 40000 [PNU]/mL
• Pharm Classes: Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 36987-1960-3

30 mL in 1 VIAL, MULTI-DOSE (36987-1960-3)

• Marketing Start Date: 1972-08-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 36987-1960-2 [36987196002]

Curvularia inaequalis INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1960-3 [36987196003]

Curvularia inaequalis INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1960-4 [36987196004]

Curvularia inaequalis INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1960-1 [36987196001]

Curvularia inaequalis INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
CURVULARIA INAEQUALIS	40000 [PNU]/mL

OpenFDA Data

• SPL SET ID: 8559987a-4127-45d1-81c8-9bce75e85db3
• Manufacturer:
  • Nelco Laboratories, Inc.
• UNII:
  • 3F36V0451W
  • D1A2NG69CK
  • 2072U60DUI
  • 62TY3X4N9Z
  • 3Y1PE1GCIG
  • TGO054E31O
  • 4K7Z7K7SWG
  • V4OQR60A5P
  • UPX000VMIF
  • TBW53313S7
  • C7000B9PQI
  • BV82OL2IZ8
  • 978D8U419H
  • 3LN5B70U4W
  • QBN8K7055X
  • O0HJ02QBWN
  • 87U156LEN7
  • 49W168AES4
  • X88DF51T48
  • 199I7J3JIV
  • 5016WB8B8A
  • CA33Q4013Q
  • 5964J742O8
  • 3J888Y9L13
  • 4ZWY20GTGO
  • 8476849N1Y
  • 9IOA40ANG6
  • 52B29REC7H
  • XQ14H1462M
  • YIH315U1TU
  • W042YAB8JC
  • 4D7G21HDBC
  • D7401PWY6E
• RxNorm Concept Unique ID - RxCUI:
  • 1006305
  • 967955
  • 968200
  • 967545
  • 967910
  • 1011993
  • 1012320
  • 889536
  • 1012106
  • 966960
  • 307874
  • 968458
  • 889577
  • 1010862
  • 1010908
  • 968486
  • 1012053
  • 967047
  • 1012154
  • 1012039
  • 1012037
  • 1006337
  • 1012174
  • 1006294
  • 889606
  • 966691
  • 968540
  • 966668
  • 967059
  • 905081
  • 1012049
  • 968153
  • 1012045
• Pharm Class PE:
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Increased Histamine Release [PE]
• PHarm Class EPC:
  • Non-Standardized Fungal Allergenic Extract [EPC]
• NUI Code:
  • N0000185001
  • N0000175629
  • N0000171131
  • N0000185372
  • N0000169106
  • N0000184306

Pharmacological Class

• Non-Standardized Fungal Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Fungal Proteins [CS]
• Allergens [CS]

NDC Crossover Matching brand name "Curvularia inaequalis" or generic name "Curvularia Inaequalis"

NDC	Brand Name	Generic Name
36987-1960	Curvularia inaequalis	Curvularia inaequalis
0268-0971	CURVULARIA	CURVULARIA INAEQUALIS